Spokane Employee Health Premiums to Rise 27% Next Year

The city will cover up to 80% of the increase for six months while it explores joining a statewide insurance provider.

Updated on Nov. 19, 2026 in Business

Bold flat-color editorial illustration of stacked shipping cartons and cargo crates on a loading dock in navy, cream, and rust, evoking municipal cost pressure.
Spokane's city government said Tuesday that employee health premiums will rise 27% next year, after a 25% increase last year, as pharmaceutical costs strain its self-funded plan. AI Illustration. Upload story photo >

Live Poll

Do you think healthcare costs for your household are getting better or worse?

Spokane city employee health premiums are set to increase 27% next year, after a 25% rise last year. The city, which is self-insured, has changed pharmacy benefit managers to try to lower pharmaceutical costs.

Why it matters

Pharmaceutical costs made up about 30% of the city's $23.3 million in medical claims during the first nine months of the year. Costs for some medications can reach $800,000 per year, putting pressure on the city's self-funded plan.

Premiums are projected to rise 27% next year, following a 25% increase last year, with pharmaceuticals accounting for about 30% of the city's $23.3 million in medical claims over the first nine months. It remains unclear whether the city will secure a new insurance provider to lessen its share of the increase.

The players

Spokane City Government

The municipal government of Spokane, Washington, which is self-insured and provides health coverage to its employees.

The details

The city negotiated a tentative agreement with its largest labor union to cover half of the pending premium increase. It will cover as much as 80% of the price hike for the next six months while it explores joining a large statewide insurance provider.

Timeline

  1. First nine months of the year: pharmaceuticals make up about 30% of medical claims.

  2. Last year: premiums increased 25%.

  3. Next year: premiums expected to rise 27%.

  4. Next six months: city covers up to 80% of the increase while it explores a new provider.

Market Landscape

Orphan drugs for rare conditions are projected by 2030 to make up a fifth of an estimated $1.6 trillion in worldwide prescription drug sales. Spokane's premium increases reflect that same pressure, as newly available gene therapies can cost as much as $4.25 million per dose.

Spokane city employees face a projected 27% premium increase next year, with the city absorbing up to 80% of the hike for six months. If no new provider is found, the city's share drops to 50% for the rest of the year, leaving employees to bear more of the cost.

The takeaway

Rising pharmaceutical costs, especially for rare-disease drugs, are now a direct driver of public employee health premiums. Employees and budget planners should track whether the city secures a statewide provider before the next premium cycle.

Further reading

Explore more on Healthcare coverage of how pharmaceutical costs are reshaping employer-sponsored insurance.

Source note: This article includes information reported by The Spokesman Review.

Live Poll

Do you think healthcare costs for your household are getting better or worse?